Multiple Myeloma Treatment in India

Multiple Myeloma Treatment in India

Many diseases are hard to recognize in their early stages because of the lack of any warnings at all. Most people who have multiple myeloma experience symptoms such as prolonged fatigue, pain in bones, and infections that last for many months. Since these symptoms could be confused with ordinary aging symptoms, the diagnosis of the disease becomes possible only when it has been progressing for a long time already.

Multiple myeloma is a kind of blood cancer that develops in plasma cells, which exist in bone marrow. Multiple myeloma treatment in India today includes modern methods of treatment such as drug therapy and even stem cell transplant.

Click here

Get Free Consultation Now

What Is Multiple Myeloma?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell that normally produces antibodies to help the body fight infections. In this disease, abnormal plasma cells grow uncontrollably and crowd out healthy blood cells, which can eventually damage the kidneys and weaken the immune system.

Early Signs and Symptoms of Multiple Myeloma

Symptoms tend to develop gradually. Identifying symptoms early helps with diagnosing the disease early:

  • Bone Pain: Consistent pain due to damaged bones in the back and/or ribs.
  • Fatigue: Consistent tiredness when healthy cells are outnumbered by cancer cells.
  • Issues with Kidneys: Frequent thirst or unusual urination habits due to the impact of proteins on the kidneys.

Causes and Risk Factors of Multiple Myeloma

  • Age: Ageing of individuals is one of the risk factors associated with multiple myeloma.
  • History of blood cancer in the family: Family history of blood cancer is regarded as a risk factor for multiple myeloma.
  • Obesity: Being overweight is known to be one of the risk factors for multiple myeloma.

How Multiple Myeloma Is Diagnosed in India

There are various methods used by medical professionals to diagnose and develop treatment for this condition. Testing of blood or urine helps to detect any abnormalities in proteins that are associated with the development of the disease. Bone marrow biopsy is a definitive test to check for abnormalities in plasma cells in the bone marrow. Imaging studies include MRI or PET scans to check the extent of bone damage due to the disease.

Stages of Multiple Myeloma Treatment in India

Multiple myeloma is staged based on disease severity and its impact on the body. Early-stage disease involves fewer symptoms and less organ involvement.

  • Advanced stages involve greater impact on the bones, kidneys, and blood.
  • Staging is an important step that helps doctors decide the most suitable treatment approach.

Chemotherapy, Targeted Therapy, and Immunotherapy

  • Chemotherapy: Operates by targeting the fast-growing cancer cells to manage the disease.
  • Targeted Therapy: Is aimed at targeting the proteins that are essential for myeloma cell survival.
  • Immunotherapy: Enables the immune system to better recognize and fight the cancer.
  • Adverse Effects and Treatment: These methods may cause adverse effects such as tiredness, nausea, increased chances of getting infections, and these will be managed by the treatment team.
  • The Treatment Regimen in India: Modern treatment usually involves the use of these methods to better manage the disease and prolong the remission period.

Stem Cell Transplant for Multiple Myeloma

Transplantation with stem cells is frequently recommended in cases where the patient can benefit from a prolonged disease-free interval. The procedure of multiple myeloma treatment in India includes an autologous transplantation, wherein the patient’s stem cells are harvested in advance, after which a course of chemotherapy at very high doses is prescribed, in order to kill off all unhealthy cells in the bone marrow, followed by returning the same patient’s healthy stem cells back into their body to regenerate bone marrow and start manufacturing healthy blood cells once again. It should be noted that multiple myeloma is normally considered a treatable condition, though currently not a curable one.

Managing Bone Health and Kidney Problems

Myeloma may have the effect of weakening bones and affecting kidney function, hence requiring management for this condition. Some of the ways through which medical practitioners will undertake this include:

  • Bone Management: Through the administration of drugs that will help to improve bone strength to prevent any risk of fracture during therapy.
  • Kidney Management: Taking sufficient fluids to support kidney functioning by preventing abnormal protein buildup.
  • Monitoring: Testing for the levels of blood, especially calcium, among others, to enhance quality of life.

Long-Term Care and Regular Monitoring

Even after successful treatment, long-term monitoring remains essential, since multiple myeloma commonly relapses over time. Doctors regularly check blood tests and bone marrow response to detect any early signs of disease returning. This ongoing follow-up care is a permanent part of managing the condition, helping patients maintain stability and quality of life for years.

Multiple Myeloma Treatment in India Cost

Multiple Myeloma Treatment in India typically costs around $5,000 to $40,000, depending on the treatment approach and complexity of the disease. Drug-based treatment may be toward the lower end, while autologous stem cell transplantation, advanced therapies, or complex treatment plans may cost more.

The exact cost depends on the patient’s disease stage and risk profile, treatment protocol, number of treatment cycles, targeted or immunotherapy medicines, stem cell transplant requirements, diagnostic investigations, hospital stay, supportive care, and management of complications. Advanced therapies, prolonged hospitalization, or transplant-related complications may further increase the overall cost. These figures are general estimates, not fixed quotes. Medicsaz can provide a personalized estimate after a partner hematologist reviews the patient’s medical records and treatment requirements.

How Medicsaz Supports Your Multiple Myeloma Treatment in India Journey

Medicsaz connects international patients with vetted partner hospitals and experienced hematologists and hemato-oncology specialists for Multiple Myeloma Treatment in India. The team assists with medical record review, hospital and specialist matching, treatment and cost estimates, stem cell transplant coordination where required, travel and visa support, accommodation, and coordination throughout the patient’s treatment journey.

For patients exploring Multiple Myeloma Treatment in India, Medicsaz can help identify an appropriate hematologist and treatment approach based on the patient’s medical records, disease status, transplant eligibility, and clinical requirements.

Conclusion

Although multiple myeloma is a serious disease affecting the blood and bones, early detection and modern treatment can significantly improve outcomes and quality of life. Multiple Myeloma Treatment in India offers a comprehensive approach with specialized hematology teams and advanced treatment options aimed at controlling the disease effectively. With consistent treatment and regular follow-up, many patients are able to achieve long periods of remission and maintain a good quality of life.

Frequently Asked Questions

Is multiple myeloma curable?

Multiple myeloma is generally considered a treatable but not currently curable condition, meaning treatment aims to control the disease and achieve long periods of remission rather than a permanent cure. Many patients live well for years with ongoing treatment and monitoring.

For multiple myeloma, transplant typically uses the patient’s own stem cells (autologous transplant), collected before high-dose chemotherapy and then reinfused afterward, rather than cells from a donor. This is different from the donor-based (allogeneic) transplants often used for conditions like leukemia or thalassemia.

Common signs include persistent bone pain (especially in the back or ribs), ongoing fatigue, and kidney-related symptoms like increased thirst or changes in urination. Because these symptoms can resemble normal aging or other conditions, persistent symptoms should be evaluated by a doctor.

Yes, chemotherapy, targeted therapy, and immunotherapy can all cause side effects like fatigue, nausea, and increased infection risk due to their effects on blood cell counts. Your care team will monitor for these throughout treatment and help manage them as they arise.

Abnormal proteins produced by cancerous plasma cells can build up and damage the kidneys’ filtering system over time. This is why kidney function is closely monitored throughout diagnosis and treatment, alongside supportive measures like adequate fluid intake.

Yes, relapse is common with multiple myeloma even after successful initial treatment, which is why long-term monitoring remains an essential part of care. Regular blood tests and follow-up visits help catch any signs of relapse early, allowing for timely adjustments to treatment.

Medically Reviewed

This page on Multiple Myeloma Treatment in India has been medically reviewed by Dr. Rashid Ali, MBBS, a Delhi Medical Council–registered practitioner (Registration No. DMC/R/36289), to ensure it reflects accurate, current, and evidence-based medical information.

At Medicsaz, every treatment page is checked by a licensed doctor before publication, not written by a marketing team alone. Dr. Rashid Ali review covers the accuracy of procedures, terminology, and claims described on this page, so patients researching Multiple Myeloma Treatment in India can rely on what they read here to make informed decisions.

Last medically reviewed: 09/09/2026

You can independently verify Dr. Rashid Ali’s registration on the Delhi Medical Council’s official website using Registration No. DMC/R/36289, or read more about his role as Medicsaz’s medical reviewer on his reviewer profile page.